Howard Rhodes - OmniVision Technologies Chief Technical Officer
Executive
Dr. Howard Rhodes is Chief Technical Officer of OmniVision Technologies Inc. From August 2005 to February 2012 Dr. Rhodes served as our Vice President of Process Engineering since 2012.
| Age | 65 |
| Tenure | 12 years |
| Professional Marks | Ph.D |
| Phone | 408-567-3000 |
| Web | http://www.ovt.com |
OmniVision Technologies Management Efficiency
The company has return on total asset (ROA) of 0.02 % which means that it generated a profit of $0.02 on every $100 spent on assets. This is way below average. OmniVision Technologies' management efficiency ratios could be used to measure how well OmniVision Technologies manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 32.09 M in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. OmniVision Technologies has a current ratio of 5.18, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist OmniVision Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, OmniVision Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like OmniVision Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for OmniVision to invest in growth at high rates of return. When we think about OmniVision Technologies' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Celia Catlett | Texas Roadhouse | 41 | |
| Juan DiazCartelle | Microbot Medical | 48 | |
| Patrik Jeanmonod | Cytek Biosciences | 57 | |
| Philippe Busque | Cytek Biosciences | N/A | |
| Michael Bailen | Texas Roadhouse | N/A | |
| Valerie JD | Cytek Biosciences | 48 | |
| Tom Fox | Tandem Diabetes Care | N/A | |
| Giedrius Zunda | Alvotech | N/A | |
| David Esq | Tandem Diabetes Care | 54 | |
| Sean Tresvant | Yum Brands | 53 | |
| Ali Shorooghi | Alphatec Holdings | 38 | |
| Jodi Dyer | Yum Brands | 36 | |
| Anne Byerlein | Yum Brands | 55 | |
| Shannon Hennessy | Yum Brands | N/A | |
| David Monroe | Texas Roadhouse | 57 | |
| Elizabeth Gasser | Tandem Diabetes Care | 48 | |
| Christina Siniscalchi | Alvotech | N/A | |
| Joe Park | Yum Brands | N/A | |
| Cortney Terry | Texas Roadhouse | N/A | |
| Sandra Casaca | Alvotech | N/A | |
| Allen Poirson | Cytek Biosciences | 64 | |
Management Performance
| Return On Asset | 0.02 |
OmniVision Technologies Leadership Team
Elected by the shareholders, the OmniVision Technologies' board of directors comprises two types of representatives: OmniVision Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OmniVision. The board's role is to monitor OmniVision Technologies' management team and ensure that shareholders' interests are well served. OmniVision Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OmniVision Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Zille Hasnain, Vice President - Quality and Reliability | ||
| John Li, VP of System Technologies | ||
| Howard Rhodes, Chief Technical Officer | ||
| Raymond Wu, Co-Founder and Pres | ||
| Ray Cisneros, Senior Vice President - Worldwide Sales and Sales Operations | ||
| Joseph Jeng, Independent Director | ||
| Vicky Chou, Sr. VP of Global Management and General Counsel | ||
| Shaw Hong, Co-Founder, Chairman and CEO | ||
| Anson Chan, CFO and VP of Fin. | ||
| Dwight Steffensen, Independent Director | ||
| Henry Yang, COO and Director |
OmniVision Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is OmniVision Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.02 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 1.34 B | |||
| Shares Outstanding | 57.56 M | |||
| Shares Owned By Insiders | 1.48 % | |||
| Shares Owned By Institutions | 65.90 % | |||
| Number Of Shares Shorted | 2.35 M | |||
| Price To Earning | 32.86 X | |||
| Price To Book | 1.43 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in OmniVision Stock
If you are still planning to invest in OmniVision Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OmniVision Technologies' history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |